Skip to content

Iron Deficiency and Anemia in Cardiac Surgery

Iron Deficiency and Anemia in Cardiovascular Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04980911
Acronym
DFACCVM
Enrollment
1711
Registered
2021-07-28
Start date
2021-04-12
Completion date
2022-03-18
Last updated
2022-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Cardiac Surgery

Brief summary

Anemia and preoperative iron deficit in cardiac surgery are associated by an increased volume of transfusion and an increase in complications and/or mortality. Recent studies have shown that EPO and iron administration the days preceding the operation results in a reduction of perioperative transfusion for patients with preoperative anemia.

Interventions

None listed

Sponsors

Centre Hospitalier Régional Metz-Thionville
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with cardiac surgery * With iron deficiency with or without anemia

Exclusion criteria

* Anemia without iron deficiency * Iron overload * Jehovah's witnesses * Endocarditis * Treating neoplasia * Uncontrolled hypertension * With infection * Alfa-epoetin hypersensitivity * Hypersensitivity of hamster's protein * Erythroblastopenia induced by erythropoietin * Ferinject or mannitol allergy

Design outcomes

Primary

MeasureTime frameDescription
Number of transfusionDay 7number of perioperative and post-operative transfusion

Secondary

MeasureTime frameDescription
Number of post operative complicationsDay 7Number of post-operative complications
Percentage of deathDay 7Percentage of post-operative death

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026